Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Kawasaki disease (KD) is rare, with fewer than 6,000 diagnosed cases per year in the United States. It is most common in infants and young children and causes inflammation in the walls of some blood vessels in the body.

Related Keywords

San Diego ,California ,United States ,University Of California San Diego ,University Of California Davis ,Kavita Sharma ,Sonia Jain ,Emily Henderson ,Adriana Tremoulet ,Katherine Kim ,Supriya Jain ,Dongngan Truong ,Ben Croker ,Beth Printz ,Samantha Roberts ,Janec Burns ,James Wood ,David Michalik ,Multicenter Study Group ,Indiana University School Of Medicine ,University Of Utah Primary Children Hospital ,Patient Centered Outcomes Research Institute ,University Of Texas Southwestern Medical Center ,Department Of Pediatrics ,Children Health ,Kawasaki Disease Research Center ,Uc San Diego School Of Medicine ,California San Diego School ,Diego School ,Rady Children ,Adolescent Health ,Clinical Investigation ,Adolescent Health Looking ,Negar Ashouri ,Maria Fareri Children ,Miller Children ,Hospital Long Beach ,Texas Southwestern Medical Center ,Primary Children ,Indiana University School ,California Davis ,Kawasaki Disease ,Abdominal Pain ,Antibodies ,Anti Inflammatory ,Asthma ,Flood ,Blood Vessels ,Children ,Clinical Trial ,Coronavirus ,Diarrhea ,Fever ,Heart ,Heart Disease ,Hospital ,Immune System ,Mmunoglobulin ,Inflammation ,Infliximab ,Medicine ,Eutrophils ,Rain ,Cash ,Research ,Espiratory ,Cars ,Ars Cov 2 ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Vomiting ,